Skip to content
Search

Latest Stories

NICE welcomes six newly appointed board members

The Department of Health and Social Care (DH) has appointed six new non-executive directors to the National Institute for Health and Care Excellence (NICE) board.

The new appointees who join the NICE are from a range of backgrounds in the medical and health technology sector and bring an impressive array of expertise to the board, the NICE said.


They start from April 1.

Welcoming the newly appointed board members, Sharmila Nebhrajani, chair of NICE, said: “I am delighted to welcome these six outstanding individuals to the NICE Board. They join us at an exciting and important time as we launch a new strategy and begin to transform the way we work.

“Each bring a wealth of experience from careers in innovation and data science, life sciences and medtech, and digital publishing - all critical elements of our future work. I look forward to working with them in the coming weeks and months.”

The six new non-executive directors are:

Mark Chakravarty Mark Chakravarty

Dr Mark Chakravarty, a business leader and a trained physician with 20 years’ experience across organisations including Novartis, Procter & Gamble and the NHS. Most recently he was the global Head of Communications and Patient Advocacy at Novartis Pharmaceuticals. He is also a member of the NICE Appeal Panel and was a member of the NICE Technology Appraisal Committee from 2003 to 2012.

________________________________________________________________________

Jackie Fielding Jackie Fielding

Jackie Fielding has been in the healthcare industry for around 30 years and for the last decade was Vice President of Medtronic UK/Ireland. She has held a number of external posts alongside her role in Medtronic including Chair of the British Cardiovascular Intervention Association, council member of British Cardiovascular Intervention Society, and Vice Chair at the Association of British HealthTech Industries. Jackie is an advocate for authentic leadership, diversity and inclusion.

________________________________________________________________________

Gary Ford Headshot Gary Ford

Professor Gary Ford has been a leading figure in stroke care for many years and developed the first thrombolysis protocol for acute stroke in England as well as the Face Arm Speech Test (FAST), now used to increase public and professional awareness of stroke. He remains a practicing clinician as a consultant stroke physician at Oxford University Hospitals NHS Foundation Trust and is also Professor of Stroke Medicine at the University of Oxford. Gary was appointed Chief Executive Officer of the Oxford Academic Health Science Network (AHSN) in 2013, and is Vice Chair of the national AHSN Network.

________________________________________________________________________

Sir Bruce Keogh headshot Sir Bruce Keogh

Professor Sir Bruce Keogh held the chair of Cardiac Surgery at University College London before being appointed Medical Director of the NHS and Director General in the Department of Health migrating to National Medical Director of NHS England. For a decade he was the professional lead for doctors in the NHS and was responsible for clinical policy and strategy, clinical leadership and innovation across the service.

In the Department of Health and Social Care he was the sponsor for NICE, the Healthcare Commission and the National Patient Safety Agency. Sir Bruce has also served on the boards of the Commission for Health Improvement and Healthcare Commission between 2002-2007. He is currently Chair of the Birmingham Women’s and Children’s NHS Foundation Trust.

________________________________________________________________________

Alina Lourie head shot Alina Lourie

Alina Lourie has had a long career in publishing and information within the private sector, including 16 years at Thomson Reuters. Latterly she was Managing Director of the publishing arm of the Royal Pharmaceutical Society. Currently, Alina holds a portfolio of Board and advisory positions across a number of professional and academic bodies, including The Institute of Engineering and Technology, The Royal Society of Chemistry and Manchester University Press.

________________________________________________________________________

Justin Whatling Justin Whatling

Dr Justin Whatling has over 20 years’ experience in using technology and informatics to transform outcomes for patients. A medical doctor by training, he is currently Vice President for International Public Sector Health for Cerner outside of the USA.

Justin is also a visiting professor in health informatics in the Faculty of Population Health Science and Institute of Digital Health at UCL. He has a strong interest in entrepreneurship and developing professionalism for health informatics, and has run summer schools for health tech start-ups with the British Computer Society and techUK.

More For You

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.

Keep ReadingShow less
Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.

Keep ReadingShow less
NHS England restructures leadership with new executive team

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025.

Getty Images

NHS England announces new executive team to lead transformation

Sir James Mackey will be leading NHS England’s transition into the Department of Health and Social Care (DHSC), along with the incoming team.

He will officially take up the role as the new chief executive officer of NHS England on 1 April 2025, replacing Amanda Pritchard, who is stepping down at the end of this month.

Keep ReadingShow less
Community Pharmacies advised to reduce opening hours and services

Community Pharmacies advised to reduce opening hours and services

Breaking news: Pharmacies advised to reduce opening hours and services from April 1st

The government has been warned that community pharmacies will take collective action and reduce opening hours and services from April 1st unless there is an imminent clarity on a new funding contract.

The National Pharmacy Association (NPA) on Tuesday (17) announced that will advise its 6000 member pharmacies in England to take the unprecedented step in the face of what it has described as an April cliff-edge that will see a range of financial burdens placed on the sector.

Keep ReadingShow less
More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

Weight-loss injections can cause gallstones, warns pharmacist

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.

Keep ReadingShow less